🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: \- The current standard of care for advanced lung cancer and c...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2011-02-08
Trial ID
NCT01306045
This randomized phase II trial studies how well selumetinib and Akt inhibit...
Status
Completed
Location
The University of Arizona Cancer Center-Orange Grove Campus
Start Date
2012-08
Trial ID
NCT01658943
Treatments Being Tested
This study will investigate the safety and tolerability of combination ther...
Status
Completed
Location
Multiple Locations
Start Date
2009-11-23
Trial ID
NCT01021748
Background: \- MK-2206 and AZD6244 (Selumetinib) are experimental cancer t...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2011-03
Trial ID
NCT01333475
Treatments Being Tested
This phase II trial studies how well selumetinib and Akt inhibitor MK2206 w...
Status
Terminated
Location
Emory University
Start Date
2012-01
Trial ID
NCT01519427
Treatments Being Tested
This phase II trial studies how well selumetinib and Akt inhibitor MK-2206 ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-01
Trial ID
NCT01859182
Different people have different biomarkers (chemical "markers" in the blood...
Status
Completed
Location
Yale Universtiy
Start Date
2011-06-02
Trial ID
NCT01248247